Correlation Between ZyVersa Therapeutics and Evaxion Biotech
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Evaxion Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Evaxion Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Evaxion Biotech AS, you can compare the effects of market volatilities on ZyVersa Therapeutics and Evaxion Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Evaxion Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Evaxion Biotech.
Diversification Opportunities for ZyVersa Therapeutics and Evaxion Biotech
0.9 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between ZyVersa and Evaxion is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Evaxion Biotech AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evaxion Biotech AS and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Evaxion Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evaxion Biotech AS has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Evaxion Biotech go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Evaxion Biotech
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Evaxion Biotech. But the stock apears to be less risky and, when comparing its historical volatility, ZyVersa Therapeutics is 1.16 times less risky than Evaxion Biotech. The stock trades about -0.07 of its potential returns per unit of risk. The Evaxion Biotech AS is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 689.00 in Evaxion Biotech AS on September 2, 2024 and sell it today you would lose (523.00) from holding Evaxion Biotech AS or give up 75.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Evaxion Biotech AS
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Evaxion Biotech AS |
ZyVersa Therapeutics and Evaxion Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Evaxion Biotech
The main advantage of trading using opposite ZyVersa Therapeutics and Evaxion Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Evaxion Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evaxion Biotech will offset losses from the drop in Evaxion Biotech's long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| Evaxion Biotech vs. Tff Pharmaceuticals | Evaxion Biotech vs. Eliem Therapeutics | Evaxion Biotech vs. Inhibrx | Evaxion Biotech vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |